Comparison of different pharmacological interventions on enzymatic parameters during acute myocardial infarction

Area of Science:

• Cardiology
• Pharmacology
• Biomedical Engineering

Background:

• Acute myocardial infarction (AMI) is a dynamic process where interventions can modify infarct size.
• Early pharmacological treatments are crucial for reducing ischemic injury during AMI.

Purpose of the Study:

• To evaluate the effects of different pharmacological interventions on reducing enzymatic infarct size in AMI patients.
• To assess the impact of treatment timing on infarct size reduction.

Main Methods:

• Studied 166 AMI patients admitted within 6 hours of chest pain, treated with single-agent therapy for 72 hours.
• Calculated enzymatic infarct size (IS) using serial creatine kinase isoenzyme MB (CK-MB) determinations and a compartmental model.
• Compared six treatment groups: antiplatelet drugs, anticoagulants, thrombolytic therapy, calcium channel blockers, nitrates, and beta-blockers.

Main Results:

• No significant differences in estimated IS or elimination constant (Kd) were observed across the six treatment groups.
• Streptokinase treatment was associated with a higher release constant (Ka) and shorter time to peak CK-MB.
• Early treatment (≤2 hours post-chest pain) favorably impacted enzymatic IS exclusively in patients receiving calcium channel blockers (P < 0.005).

Conclusions:

• Early administration of calcium channel blockers appears beneficial in reducing infarct size in acute myocardial infarction.
• Further research is warranted to explore the specific mechanisms and optimal use of calcium channel blockers in AMI management.